There were 1,351 press releases posted in the last 24 hours and 429,888 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced Endometrial Cancer

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image